000 01173 a2200313 4500
005 20250518025132.0
264 0 _c20200217
008 202002s 0 0 eng d
022 _a1534-3111
024 7 _a10.1007/s11906-019-0924-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aManolis, Antonis A
245 0 0 _aEplerenone Versus Spironolactone in Resistant Hypertension: an Efficacy and/or Cost or Just a Men's Issue?
_h[electronic resource]
260 _bCurrent hypertension reports
_c03 2019
300 _a22 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAldosterone
650 0 4 _aAntihypertensive Agents
_xtherapeutic use
650 0 4 _aEplerenone
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aHypertension
_xdrug therapy
650 0 4 _aMineralocorticoid Receptor Antagonists
_xtherapeutic use
650 0 4 _aSpironolactone
_xtherapeutic use
700 1 _aManolis, Theodora A
700 1 _aMelita, Helen
700 1 _aManolis, Antonis S
773 0 _tCurrent hypertension reports
_gvol. 21
_gno. 3
_gp. 22
856 4 0 _uhttps://doi.org/10.1007/s11906-019-0924-0
_zAvailable from publisher's website
999 _c29434079
_d29434079